Antibiotic-resistant lactose-fermenting bacteria were recovered from the feces of 20 of 25 burn patients studied. Of the Escherichia coli isolated from patients receiving antibiotic treatment, 81.5% were shown to be infectiously resistant; only 32% of the E. coli recovered from patients not receiving antibiotics were shown to be harboring R factors. Three resistance patterns, ampicillin-chloramphenicol-streptomycin-kanamycin, ampicillin-tetracycline, and ampicillin-streptomycin, accounted for 25.2, 20.3, and 15.4%, respectively, of the total R factors identified.
The demonstration of infectious drug resistance among the Enterobacteriaceae and other unrelated gram-negative bacteria (7) has led to renewed interest in the incidence of antibiotic resistance among the gram-negative bacteria. Gill (4) suggested that antibiotic usage is the major selective force favoring the emergence of drug-resistant bacteria. Anderson (1) demonstrated that infectious drug resistance increased with antibiotic usage among livestock. Datta (2) recently suggested that the majority of all antibiotic resistant, clinically isolated gram-negative bacteria harbor R factors. There is little information currently available on the effect of antibiotic treatment on the incidence of infectious drug resistance in man.
The purpose of this study was to assess the effect of antibiotic treatment on the incidence of R factors among lactose-fermenting bacteria isolated from man. Burn patients were selected as an ideal group for study since it may be assumed that these individuals prior to adrnission to the hospital are representative of the normal presumably healthy population. In such patients, it should be possible to gain an insight into the effect of antibiotic treatment on infectious drug resistance among the bowel bacteria by collecting fecal specimens both before and after drug treatment and analyzing for the presence of R factors in the drug-resistant bacteria isolated. The data presented here represent the result of an initial investigation.
MATERIAIlS AND METHODS
Fecal specimens. Fecal specimens were obtained from burn patients at the University Hospital, Birmingham, Ala., upon admission and at weekly intervals thereafter. A total of 47 specimens from 25 patients were studied. Patients' charts were reviewed at routine intervals to determine the antibiotic treatment, if any, being administered.
Isolation of resistant bacteria A portion of fecal material (about the size of a pea) was emulsified in 0.5 ml of TM buffer [1. to be tested onto Brain Heart Infusion Agar (Difco). Sensi-Discs of the same type and concentration as described above were dispensed onto the surface of the seeded plates, and the resistance pattern was determined after incubation at 37 C for 18 to 24 hr.
Transfer of antibiotic resistance. Lactose-fermenting isolates found to be resistant to one or more antibiotics were used as prospective donors of resistance to an F-derivative of Escherichia coli K-12. The lactose-negative recipient, designated WI-A2 (lac), is completely susceptible to antibiotics but resistant to 250 jug of sodium azide per ml (5, 6) . Mating procedures were carried out by mixing 0.1 and 0.2 ml of overnight broth cultures of the prospective donor and recipient, respectively, in 2 ml of sterile Brain Heart Infusion Broth (Difco). The mixtures were incubated for 18 to 24 hr as a stationary culture. A swabful of each mixture was smeared onto MacConkey Agar plates containing a single appropriate antibiotic and 250 ,ug of sodium azide per ml. In this manner, 12 mixtures could be placed on each plate. The media used were selective for antibiotic-resistant recombinants of WI-A2 (lac-) in that growth of the prospective donor was prevented by sodium azide and growth of the recipient was prevented by an antibiotic. After incubation at 37 C for 48 hr, lactose-negative recombinants were picked and streaked to the same selective medium to ensure pure colony isolation. The antibiotic-resistance pattern of at least one recombinant colony from each mating mixture was determined as described above to ascertain whether partial or complete transfer of resistance from donor to recipient had taken place.
Antibiotics. Chloramphenicol was provided by Parke, Davis & Co.; ampicillin (Penbritin) was supplied by Ayerst Laboratories; and gentamicin (Garamycin) was provided by Schering Corp. Appropriate concentrations of each antibiotic used in selective media were prepared in sterile distilled water, and stock solutions were maintained at -10 C.
RESULTS
Drug resistance and transferability among bacteria isolated from patients receiving antibiotics. Drug-resistant lactose-fermenting bacteria were recovered from 20 of the 25 burn patients studied. Resistant bacteria were recovered from all 11 patients who received antibiotics. The patients included in the treated group received penicillin, ampicillin, nitrofurantoin, and gentamicin with the majority receiving prophylactic doses of peniciUlin.
A total of 142 lactose-positive strains were isolated from the MacConkey Agar plates containing Sensi-Discs. Further characterization of these isolates revealed that 108 were E. coli, whereas 34 belonged to the Klebsiella-Enterobacter group. The drug resistance pattern of each isolate was determined by using nine different antibiotics. The drug-resistance patterns observed as well as the incidence of infectious drug resistance among the E. coli isolates recovered Table 2 shows the incidence and transferability of resistance patterns among the 34 KlebsiellaEnterobacter strains recovered from patients receiving antibiotic treatment. All 34 strains were resistant to ampicilhin, whereas 31 (91%), 30 (87%), and 21 (62%), respectively, were resistant to chloramphenicol, streptomycin, or nalidixic acid. Of the 34 strains studied, 13 or 38% were multiply resistant to ampicillin, chloramphenicol, streptomycin, and nalidixic acid. In contrast to the 81.5% of E. coli strains shown to be infectiously resistant, only 29.4% of the KlebsiellaEnterobacter isolates harbored R factors.
Drug resistance and bansferability among bacteria isolated from patients not receiving antibiotics. Of the 18 patients studied who were not receiving antibiotic treatment, 13 were found to have drug-resistant, lactose-positive bacteria in their fecal flora. Seventy-seven strains were recovered from the primary isolation medium. After purification and further characterization, 62 of the isolates were identified as E. coli and 15 as belonging to the Klebsiella-Enterobacter group. The drug-resistance patterns of all 77 strains were determined, and each strain was grown in mixed culture with the drug-susceptible recipient to assay for resistance transfer. The incidence and transferability of resistance patterns among the E. coli recovered from patients not receiving antibiotics are shown in Table 3 . One pattern, ampicillin-streptomycin-tetracycline, accounted for 35.5% of all the resistance patterns observed. Of the 62 E. coli strains studied, 52, 52, and 35 (84, 84, and 57%) were resistant to ampicillin, streptomycin, or tetracycline, respectively.
It is of interest that only 15 (24%) of the E. coli recovered from the untreated group were resistant to four or more antibiotics, whereas 52 (46%) from the treated group were resistant to four or more antibiotics. Furthermore, only 32% of the E. coli recovered from the untreated group were found to be infectiously drug resistant; 81.5% isolated from the treated group transferred resistance. These results indicate antibiotic treatment as a selective force for R factors. However, the possibility exists that infectiously resistant bacteria could have been hospital-acquired since the median hospitalization for the treated group (45 days) was three times greater than the untreated group (15 days). This appears unlikely since three patients receiving no antibiotics and hospitalized for periods equal to the treated group showed no increase in the frequency of the presence of R factors. In agreement with our results, Datta (2) found that the length of hospitalization beyond 3 weeks did not affect the number of resistant bacteria recovered from fecal specimens. However, Datta (2) demonstrated that there was a tendency to acquire drug-resistant bowel bacteria, in particular E. coli, during the first 3 weeks after admission. Datta did not determine whether the increase in resistant bacteria was due to the acquisition of resistance by originally sensitive strains or the replacement of the original strains with resistant ones.
Anderson (1) showed R factors to be composed of a resistance factor (rJ) and a resistance-transfer factor (rtf) and suggested that these components, initially independent, may recombine to form a complete R factor after conjugation of a bacterium carrying an rf and one harboring an rtf. Anderson also found that the rtf transfers at a much higher rate than the complete R factor. It would then be possible for antibiotic treatment to select for drug-resistant bacteria in the bowel and thus enrich for rf-and R factor-containing bacteria. If, after enrichment of resistant bacteria by antibiotics, a bacterium containing an rtf came in contact with those bacteria containing an rf only, the rtf and rf could recombine to produce a complete R factor after conjugation. This could account for the increase in infectious drug resistance among patients receiving antibiotics.
The conclusions to be drawn from this investigation are that multiply antibiotic-resistant coliforms are easily recovered from the feces of persons who may or may not be receiving antibiotic treatment. E. coli isolated from patients
